Myobacterium bovis peri-prosthetic hip infection with successful prosthesis retention following intravesical BCG therapy for bladder carcinoma

about

Myobacterium bovis peri-prosthetic hip infection with successful prosthesis retention following intravesical BCG therapy for bladder carcinoma

Item

http://www.wikidata.org/entity/Q36276438

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@ast

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@en

type

Item

label

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@ast

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@en

prefLabel

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@ast

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@en

P1476

Myobacterium bovis peri-prosth ...... therapy for bladder carcinoma

@en

P2093

Lucy Ping Aitchison

http://www.w3.org/2001/XMLSchema#string

Ronald Sekel

http://www.w3.org/2001/XMLSchema#string

Steven T Lindstrom

http://www.w3.org/2001/XMLSchema#string

Viran Jayanetti

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

BCG intravesical instillations: recommendations for side-effects management.

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high

Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

Pathogenesis of prosthesis-related infection.

Prosthetic joint infections: update in diagnosis and treatment.

Long-term results of intravesical therapy for superficial bladder cancer.

P304

307-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4066/AMJ.2015.2475

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283616947

http://www.w3.org/2001/XMLSchema#string

P698

26576201

http://www.w3.org/2001/XMLSchema#string

P932

4643607

http://www.w3.org/2001/XMLSchema#string